Lingyin Li

Lingyin Li, a Biochemistry professor at Stanford and breast cancer survivor, dives into the intriguing world of immunotherapy. She discusses her journey inspired by her own diagnosis and explains why T cells often struggle to target solid tumors. Lingyin reveals the groundbreaking discovery of the ENPP1 enzyme, which helps cancers evade immune detection. Her lab is working on innovative strategies to inhibit this enzyme, with promising preclinical results suggesting effective combinations for treating aggressive tumors. The future looks bright for immunotherapy!